Live from CPHI Shanghai 2025
- Categories:News
- Author:吉瑞尔
- Origin:http://www.jerelpack.com/
- Time of issue:2025-06-27
- Views:619
(Summary description)Live from CPHI Shanghai 2025 – Practical Solutions with Cold-Formed Pharmaceutical Aluminum Foil
Keywords: #CPHIShanghai #PharmaAluminumFoil #ComplianceAndCostReduction
Exhibition Highlights
Date & Location: June 24–27, 2024, Shanghai New International Expo Center, Hall N2, Booth N2F35
Engagement: Over 200 domestic pharmaceutical companies participated, with more than 30 initiating preliminary cooperation.
Technical Solutions & Measured Data
High-Barrier Aluminum Foil
Applications: Solid dosage forms such as tablets, capsules, and granules—especially for oxidation-sensitive drugs (e.g., Vitamin C) and moisture-sensitive drugs (e.g., probiotics).
Performance Parameters:
Oxygen Transmission Rate (OTR): ≤0.5 cc/m²·day (Test Report No.: NIPM-2024-AL-0032 by National Institute of Pharmaceutical Packaging Materials)
Moisture Barrier Rate: ≤0.1 g/m²·day (Tested under 40℃/75% RH conditions)
Case Study: A pharmaceutical company in East China used this foil for omeprazole enteric-coated capsules, successfully extending the product's shelf life from 18 to 24 months.
Cost-Effective Solutions
Economical Foil: 25μm thick rolls, reducing material costs by 22% compared to imported alternatives. Already adopted in three centralized procurement drugs (e.g., atorvastatin calcium tablets), with annual procurement exceeding 1,200 tons.
Mold Compatibility: Compatible with over 1,200 commonly used blister tooling interfaces. One client reduced mold changeover time from 4 hours to 30 minutes.
Regulatory Compliance Support
Documentation: Full Drug Master File (DMF) available, including material certificates, biocompatibility tests (USP <87><88>), and migration data.
Rapid Response: Technical documents required for regulatory review can be provided within 48 hours. Successfully supported seven clients through NMPA reviews.
Exhibition Achievements & Client Feedback
Signed Agreements:
Signed a 500-ton annual supply contract with a traditional Chinese medicine company in Southwest China for granule moisture-proof packaging. After replacing PVC with aluminum foil, the humidity defect rate dropped from 8% to 0.5%.
Customized an “aluminum foil + tearable film” packaging solution for a biopharmaceutical company in North China, reducing clinical trial material waste by 30%.
On-site Verification:
15 pharmaceutical companies conducted blister forming tests at the booth, achieving ≥99.5% pass rate (industry average: 97%).
A lyophilized powder injection company confirmed excellent low-temperature resistance (-40°C), fully meeting cold chain logistics requirements.
Company Core Capabilities (Facts Only)
Production Capacity: 30,000 tons annually at Jiangsu production base; minimum order 5 tons, 72-hour delivery.
Certifications: ISO 15378, GB/T 22647 (National Standard for Pharmaceutical Packaging Aluminum Foil).
R&D: Co-developed a patented "high-ductility aluminum foil" with Zhejiang University (Patent No.: ZL2023XXXXXX), reducing blister breakage rate from the industry average of 1.2% to 0.3%.
Exhibition Services
Free Pharma Aluminum Foil Technical White Paper (includes 50+ measured data points and selection guide).
On-site engineers available to answer questions on blister forming, mold matching, etc.
Contact: Manager Li – +86 138-XXXX-XXXX (available 24/7 during exhibition).
Live from CPHI Shanghai 2025
(Summary description)Live from CPHI Shanghai 2025 – Practical Solutions with Cold-Formed Pharmaceutical Aluminum Foil
Keywords: #CPHIShanghai #PharmaAluminumFoil #ComplianceAndCostReduction
Exhibition Highlights
Date & Location: June 24–27, 2024, Shanghai New International Expo Center, Hall N2, Booth N2F35
Engagement: Over 200 domestic pharmaceutical companies participated, with more than 30 initiating preliminary cooperation.
Technical Solutions & Measured Data
High-Barrier Aluminum Foil
Applications: Solid dosage forms such as tablets, capsules, and granules—especially for oxidation-sensitive drugs (e.g., Vitamin C) and moisture-sensitive drugs (e.g., probiotics).
Performance Parameters:
Oxygen Transmission Rate (OTR): ≤0.5 cc/m²·day (Test Report No.: NIPM-2024-AL-0032 by National Institute of Pharmaceutical Packaging Materials)
Moisture Barrier Rate: ≤0.1 g/m²·day (Tested under 40℃/75% RH conditions)
Case Study: A pharmaceutical company in East China used this foil for omeprazole enteric-coated capsules, successfully extending the product's shelf life from 18 to 24 months.
Cost-Effective Solutions
Economical Foil: 25μm thick rolls, reducing material costs by 22% compared to imported alternatives. Already adopted in three centralized procurement drugs (e.g., atorvastatin calcium tablets), with annual procurement exceeding 1,200 tons.
Mold Compatibility: Compatible with over 1,200 commonly used blister tooling interfaces. One client reduced mold changeover time from 4 hours to 30 minutes.
Regulatory Compliance Support
Documentation: Full Drug Master File (DMF) available, including material certificates, biocompatibility tests (USP <87><88>), and migration data.
Rapid Response: Technical documents required for regulatory review can be provided within 48 hours. Successfully supported seven clients through NMPA reviews.
Exhibition Achievements & Client Feedback
Signed Agreements:
Signed a 500-ton annual supply contract with a traditional Chinese medicine company in Southwest China for granule moisture-proof packaging. After replacing PVC with aluminum foil, the humidity defect rate dropped from 8% to 0.5%.
Customized an “aluminum foil + tearable film” packaging solution for a biopharmaceutical company in North China, reducing clinical trial material waste by 30%.
On-site Verification:
15 pharmaceutical companies conducted blister forming tests at the booth, achieving ≥99.5% pass rate (industry average: 97%).
A lyophilized powder injection company confirmed excellent low-temperature resistance (-40°C), fully meeting cold chain logistics requirements.
Company Core Capabilities (Facts Only)
Production Capacity: 30,000 tons annually at Jiangsu production base; minimum order 5 tons, 72-hour delivery.
Certifications: ISO 15378, GB/T 22647 (National Standard for Pharmaceutical Packaging Aluminum Foil).
R&D: Co-developed a patented "high-ductility aluminum foil" with Zhejiang University (Patent No.: ZL2023XXXXXX), reducing blister breakage rate from the industry average of 1.2% to 0.3%.
Exhibition Services
Free Pharma Aluminum Foil Technical White Paper (includes 50+ measured data points and selection guide).
On-site engineers available to answer questions on blister forming, mold matching, etc.
Contact: Manager Li – +86 138-XXXX-XXXX (available 24/7 during exhibition).
- Categories:News
- Author:吉瑞尔
- Origin:http://www.jerelpack.com/
- Time of issue:2025-06-27
- Views:619
Live from CPHI Shanghai 2025 – Practical Solutions with Cold-Formed Pharmaceutical Aluminum Foil
Keywords: #CPHIShanghai #PharmaAluminumFoil #ComplianceAndCostReduction
Exhibition Highlights
Date & Location: June 24–27, 2024, Shanghai New International Expo Center, Hall N2, Booth N2F35
Engagement: Over 200 domestic pharmaceutical companies participated, with more than 30 initiating preliminary cooperation.
Technical Solutions & Measured Data
High-Barrier Aluminum Foil
Applications: Solid dosage forms such as tablets, capsules, and granules—especially for oxidation-sensitive drugs (e.g., Vitamin C) and moisture-sensitive drugs (e.g., probiotics).
Performance Parameters:
-
Oxygen Transmission Rate (OTR): ≤0.5 cc/m²·day (Test Report No.: NIPM-2024-AL-0032 by National Institute of Pharmaceutical Packaging Materials)
-
Moisture Barrier Rate: ≤0.1 g/m²·day (Tested under 40℃/75% RH conditions)
Case Study: A pharmaceutical company in East China used this foil for omeprazole enteric-coated capsules, successfully extending the product's shelf life from 18 to 24 months.
Cost-Effective Solutions
Economical Foil: 145μm thick rolls, reducing material costs by 22% compared to imported alternatives. Already adopted in three centralized procurement drugs (e.g., atorvastatin calcium tablets), with annual procurement exceeding 1,200 tons.
Mold Compatibility: Compatible with over 1,200 commonly used blister tooling interfaces. One client reduced mold changeover time from 4 hours to 30 minutes.
Regulatory Compliance Support
Documentation: Full Drug Master File (DMF) available, including material certificates, biocompatibility tests (USP <87><88>), and migration data.
Rapid Response: Technical documents required for regulatory review can be provided within 48 hours. Successfully supported seven clients through NMPA reviews.
Exhibition Achievements & Client Feedback
Signed Agreements:
-
Signed a 500-ton annual supply contract with a traditional Chinese medicine company in Southwest China for granule moisture-proof packaging. After replacing PVC with aluminum foil, the humidity defect rate dropped from 8% to 0.5%.
-
Customized an “aluminum foil + tearable film” packaging solution for a biopharmaceutical company in North China, reducing clinical trial material waste by 30%.
On-site Verification:
-
15 pharmaceutical companies conducted blister forming tests at the booth, achieving ≥99.5% pass rate (industry average: 97%).
-
A lyophilized powder injection company confirmed excellent low-temperature resistance (-40°C), fully meeting cold chain logistics requirements.
Company Core Capabilities (Facts Only)
-
Production Capacity: 30,000 tons annually at Jiangsu production base; minimum order 5 tons, 72-hour delivery.
-
Certifications: ISO 15378, GB/T 22647 (National Standard for Pharmaceutical Packaging Aluminum Foil).
Exhibition Services
-
On-site engineers available to answer questions on blister forming, mold matching, etc.
-
Contact: Skylar Min – +86 13776425960 (available 24/7 during exhibition).
Scan the QR code to read on your phone
Real-time News

Online Message
Ask about our products and prices, please leave your email, and we will contact you within 24 hours.


Sweep, mobile station

Electronic business card
Address
Daqiao Industrial Park, Jiangdu, Yangzhou,China
Copyright:Yangzhou Jerel Pharmaceutical New Material Co., Ltd. Powered by www.300.cn 苏ICP备13054439号-1